Ofatumumab and High-dose Methylprednisolone in Patients With Chronic Lymphocytic Leukemia (CLL) (CRC027)

Clinical Trial ID NCT01191190

PubWeight™ 0.76^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01191190

Top papers